Core Points - Microbot Medical Inc. announced the third and final closing of its preferred investment options, resulting in the issuance of 13,989,115 shares of common stock [1][4] - The total gross proceeds from the three closings amounted to approximately $29.2 million, with potential additional proceeds of about $63 million from the exercise of short-term preferred investment options [4] Group 1: Investment Details - The first closing generated approximately $25.2 million from the exercise of options for 12,064,627 shares at prices ranging from $1.50 to $2.13 per share [2][4] - The second closing brought in approximately $1.2 million for 600,000 shares at an exercise price of $2.10 per share [2][4] - The third closing resulted in approximately $2.8 million for 1,324,488 shares at an exercise price of $2.10 per share [2][4] Group 2: Future Plans and Use of Proceeds - The company plans to utilize the net proceeds for the development, commercialization, and regulatory activities of its LIBERTY Robotic System, potential acquisitions, and general corporate purposes [4] - The new short-term series J preferred investment options will have an exercise price of $4.50 per share and will be exercisable six months after issuance [2][4] Group 3: Company Overview - Microbot Medical Inc. is focused on transforming endovascular procedures through advanced robotic technology, with its LIBERTY Endovascular Robotic System being a key product [7][8] - The company is backed by a strong intellectual property portfolio and is committed to innovation in endovascular care [8]

Group 1 - Microbot Medical Inc. (NASDAQ:MBOT) has experienced a significant decline, with a 6.93% drop in share price, closing at $3.09, amid concerns over potential dilution from a fundraising program worth $63 million [1][4]. - The company raised $25.2 million from an options exercise, covering 12.06 million shares at prices between $1.5 and $2.13 [2]. - A second offering is expected to close on October 15, with over 1.9 million shares anticipated to be exercised at $2.10 each, potentially raising around $4 million [3]. Group 2 - The net proceeds from the fundraising efforts are intended for the development, commercialization, and regulatory activities of the LIBERTY Robotic System, as well as for potential acquisitions, expansion of applications from its existing IP portfolio, and general corporate purposes [5].